Exploring Enablers and Barriers Toward COVID-19 Vaccine Acceptance Among Arabs: A Qualitative Study

Overview

Journal Int J Disaster Risk Reduct

Date 2022 Oct 4

PMID 36193257

Authors

Iffat Elbarazi

Mohamed Yacoub

Omar Ahmed Reyad

Marwa Shawky Abdou

Yasir Ahmed Mohammed Elhadi

Khalid A Kheirallah

Bayan F Ababneh

Bayan Abu Hamada

Haider M El Saeh

Nancy Ali

Azhar T Rahma

Mohamed Mostafa Tahoun

Ramy Mohamed Ghazy

Affiliations

Soon will be listed here.

Abstract

Background: With the emergence of the coronavirus disease 2019 (COVID-19) and rapid vaccine development, research interest in vaccine hesitancy (VH) has increased. Research usually focuses on quantitative estimates which largely neglected the qualitative underpinnings of this phenomenon. This study aimed to explore the beliefs and views towards COVID-19 vaccination among Arabs in different countries. Furthermore, we explored the effect of confidence in the healthcare system, misinformation, and scientific approaches adopted to mitigate COVID-19 on how individuals are following the recommended preventative actions including vaccination.

Methods: This study was based on the Strategic Advisory Group of Experts (SAGE)-VH Model: A qualitative design that utilized in-depth, online interviews. The study was conducted in seven Arab countries (Egypt, Qatar, Kingdom of Saudi Arabia, Libya, Sudan, United Arab Emirates and Jordan) from June 2020 to December 2021. Transcripts were analyzed using NVivo 12 Software.

Results: A total of 100 participants, 44 males and 56 females, of different age groups (37.1 ± 11.56 years) were interviewed. Findings revealed six themes as enablers and barriers to COVID-19 vaccination. Many participants indicated trusting the vaccines, the healthcare systems, and the vaccination policies were the main driver to get the vaccine. Participants showed concerns towards potential long-term vaccine effects. A consistent inclination towards collective responsibility, which is the willingness to protect others by own vaccination, was also reported.

Conclusion: Enablers and barriers of COVID-19 vaccination acceptance in the Arab region, from sociocultural and political perspectives, are critical to guide policymakers in designing target-oriented interventions that can improve vaccine acceptance.

Citing Articles

Post-COVID-19 pandemic immunization coverage in Algerian children: A cross-sectional study.

Ghazy R, Abadi A, Salah A, Ismail E, Youssef N, Saleeb M Medicine (Baltimore). 2025; 104(8):e41494.

PMID: 39993066 PMC: 11856980. DOI: 10.1097/MD.0000000000041494.

Psychological antecedents of vaccine inequity: keys to improve the rates of vaccination.

Hussein M, Ibrahim S, Abdel-Rahman S, Elshabrawy A, Nasr H, Yazbek S J Egypt Public Health Assoc. 2024; 99(1):31.

PMID: 39627491 PMC: 11615162. DOI: 10.1186/s42506-024-00175-7.

Development and validation of an Arabic tool for assessment of post-vaccination confidence in COVID-19 vaccines (ARAB-VAX-CONF).

Abuyadek R, Abd ElHafeez S, Tahoun M, Othman S, Omran A, Fathy N J Egypt Public Health Assoc. 2024; 99(1):28.

PMID: 39551890 PMC: 11570568. DOI: 10.1186/s42506-024-00174-8.

Hesitancy towards R21/Matrix-M malaria vaccine among Ghanaian parents and attitudes towards immunizing non-eligible children: a cross-sectional survey.

Hussein M, Kyei-Arthur F, Saleeb M, Kyei-Gyamfi S, Abutima T, Sakada I Malar J. 2024; 23(1):142.

PMID: 38734664 PMC: 11088762. DOI: 10.1186/s12936-024-04921-2.

Individual and social determinants of COVID-19 vaccine hesitancy and uptake in Northwest Syria.

Al-Abdulla O, Alaref M, Kallstrom A, Kauhanen J BMC Health Serv Res. 2024; 24(1):265.

PMID: 38429739 PMC: 10908183. DOI: 10.1186/s12913-024-10756-z.

References

Solis Arce J, Warren S, Meriggi N, Scacco A, McMurry N, Voors M . COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021; 27(8):1385-1394. PMC: 8363502. DOI: 10.1038/s41591-021-01454-y. View

Abdou M, Kheirallah K, Aly M, Ramadan A, Elhadi Y, Elbarazi I . The coronavirus disease 2019 (COVID-19) vaccination psychological antecedent assessment using the Arabic 5c validated tool: An online survey in 13 Arab countries. PLoS One. 2021; 16(11):e0260321. PMC: 8629271. DOI: 10.1371/journal.pone.0260321. View

Toth-Manikowski S, Swirsky E, Gandhi R, Piscitello G . COVID-19 vaccination hesitancy among health care workers, communication, and policy-making. Am J Infect Control. 2021; 50(1):20-25. PMC: 8511871. DOI: 10.1016/j.ajic.2021.10.004. View

Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F . HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019; 15(7-8):1615-1627. PMC: 6783136. DOI: 10.1080/21645515.2018.1564436. View

Qunaibi E, Helmy M, Basheti I, Sultan I . A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs. Elife. 2021; 10. PMC: 8205489. DOI: 10.7554/eLife.68038. View

Kumar D, Chandra R, Mathur M, Samdariya S, Kapoor N . Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res. 2016; 5:2. PMC: 4736490. DOI: 10.1186/s13584-016-0062-y. View

Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View

Graeber D, Schmidt-Petri C, Schroder C . Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany. PLoS One. 2021; 16(5):e0248372. PMC: 8109805. DOI: 10.1371/journal.pone.0248372. View

Wang J, Ji Q, Dong S, Zhao S, Li X, Zhu Q . Factors Influencing Vaccine Hesitancy in China: A Qualitative Study. Vaccines (Basel). 2021; 9(11). PMC: 8622488. DOI: 10.3390/vaccines9111291. View

10.

Saddik B, Al-Bluwi N, Shukla A, Barqawi H, Alsayed H, Sharif-Askari N . Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates. Hum Vaccin Immunother. 2021; 18(1):1-9. PMC: 8928822. DOI: 10.1080/21645515.2021.1994300. View

11.

Miller M, Castrucci B . Changing the COVID-19 Conversation: It's About Language. JAMA Health Forum. 2022; 2(2):e210020. DOI: 10.1001/jamahealthforum.2021.0020. View

12.

Carrieri V, Madio L, Principe F . Vaccine hesitancy and (fake) news: Quasi-experimental evidence from Italy. Health Econ. 2019; 28(11):1377-1382. PMC: 6851894. DOI: 10.1002/hec.3937. View

13.

Nguyen K, Srivastav A, Razzaghi H, Williams W, Lindley M, Jorgensen C . COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination - United States, September and December 2020. Am J Transplant. 2021; 21(4):1650-1656. PMC: 8250395. DOI: 10.1111/ajt.16560. View

14.

Lockyer B, Islam S, Rahman A, Dickerson J, Pickett K, Sheldon T . Understanding COVID-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK. Health Expect. 2021; 24(4):1158-1167. PMC: 8239544. DOI: 10.1111/hex.13240. View

15.

Khurshid A . Applying Blockchain Technology to Address the Crisis of Trust During the COVID-19 Pandemic. JMIR Med Inform. 2020; 8(9):e20477. PMC: 7511222. DOI: 10.2196/20477. View

16.

Peretti-Watel P, Larson H, Ward J, Schulz W, Verger P . Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. 2015; 7. PMC: 4353679. DOI: 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289. View

17.

Rieger M, Wang M . Trust in Government Actions During the COVID-19 Crisis. Soc Indic Res. 2021; 159(3):967-989. PMC: 8383026. DOI: 10.1007/s11205-021-02772-x. View

18.

Swire-Thompson B, Lazer D . Public Health and Online Misinformation: Challenges and Recommendations. Annu Rev Public Health. 2019; 41:433-451. DOI: 10.1146/annurev-publhealth-040119-094127. View

19.

Shaaban R, Ghazy R, Elsherif F, Ali N, Yakoub Y, Aly M . COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study. Int J Environ Res Public Health. 2022; 19(9). PMC: 9101365. DOI: 10.3390/ijerph19095737. View

20.

Ashmawy R, Hamdy N, Elhadi Y, Alqutub S, Esmail O, Abdou M . A Meta-Analysis on the Safety and Immunogenicity of Covid-19 Vaccines. J Prim Care Community Health. 2022; 13:21501319221089255. PMC: 8998390. DOI: 10.1177/21501319221089255. View